Telegraph.co.ukGlaxo Plans More Restructuring as Profit SinksWall Street JournalLike many of its rivals, Glaxo has turned to emerging markets in search of growth, such as India and Nigeria, where it recently gained more control over its subsidiaries. T…
Study Identifies Biomarkers for Early Risk Assessment of Acute Kidney Injury – Newswise (press release)
|
Study Identifies Biomarkers for Early Risk Assessment of Acute Kidney Injury
Newswise (press release) Newswise — ROCHESTER, Minn. — Acute kidney injury strikes large numbers of hospitalized patients, including those with no prior kidney-related illness, and is one of the most costly and deadly conditions affecting critically ill patients. Findings … Research Validates New Biomarkers For Risk Assessment Of Acute Kidney InjuryPR Newswire (press release) Astute Medical, Inc. Advancing Next Generation Acute Kidney Injury BiomarkersInternational Business Times (press release) Discovery and validation of cell cycle arrest biomarkers in human acute kidney …7thSpace Interactive (press release) MedPage Today all 5 news articles » |
Learn to prevent – The Hindu
 The Hindu |
Learn to prevent
The Hindu Over 2.5 million cases of cancer are being treated every year in India. As per the International agency for Research on Cancer ( IARC ) – WHO report, around 5.5 lakh people die of cancer every year. Men in India most commonly suffer from cancers lung … |
Robin's 100th blood donation – Brentwood Weekly News
|
Robin’s 100th blood donation
Brentwood Weekly News A LANDMARK has been achieved by an “inspirational” man after he reached a century of blood donations. Robin Greatorex, 65, made his 100th donation to the Brentwood Blood Centre, in Crescent Drive, 36 years after he made his first. It is thought his … |
BCCI institutes MAK Pataudi Memorial Lecture – NetIndian
NetIndianBCCI institutes MAK Pataudi Memorial LectureNetIndianThe Board of Control for Cricket in India (BCCI) has instituted an annual lecture as a tribute to former Indian cricket captain Mansur Ali Khan Pataudi, one of the greatest legends of the ga…
Global Brain Monitoring Market worth $1.63 Billion by 2017 – The Herald | HeraldOnline.com
|
Global Brain Monitoring Market worth $1.63 Billion by 2017
The Herald | HeraldOnline.com The “Brain Monitoring Market by Product [EEG/Magnetoencephalography (MEG)/Intracranial Pressure Monitor/Cerebral Oximeter/Transcranial Doppler] & Application [Sleep Disorders/Epilepsy/Traumatic Brain Injury/Brain Death] – Global Forecasts to 2017″ … |
2 antibodies are better than 1 – Science Codex
2 antibodies are better than 1Science CodexWe allow third-party companies to serve ads and/or collect anonymous information. These companies may use non-personally identifiable information (browser type, time and date) in order to provide advertisement…
Postcardiac transplant survival in the current era in patients receiving … – The Journal of Thoracic and Cardiovascular Surgery
Postcardiac transplant survival in the current era in patients receiving …The Journal of Thoracic and Cardiovascular SurgeryIf the patient had renal dysfunction (glomerular filtration rate <30 mL/min/1.73 m2) for 3 days after transplantation, an i…
Biogen Idec to Acquire Full Rights and Control of TYSABRI from Elan for … – Businessweek
 FRANCE 24 |
Biogen Idec to Acquire Full Rights and Control of TYSABRI from Elan for …
Businessweek … including uncertainty inherent in regulatory review of the transaction, our dependence on our three principal products, AVONEX™ (interferon beta-1a), TYSABRI and RITUXAN™ (rituximab), the importance of TYSABRI’s sales growth, uncertainty of … Biogen Idec to Acquire Full Rights and Control of TYSABRI(R) from Elan for …MarketWatch (press release) |
2 antibodies are better than 1 – EurekAlert (press release)
2 antibodies are better than 1EurekAlert (press release)Cancer drugs of the new, molecular generation destroy malignant breast tumors in a targeted manner: They block characteristic molecules on tumor cells – receptors for the hormones estrogen or prog…